Aislin Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 10-01-2025
- Paid Up Capital ₹ 1.50 M
as on 10-01-2025
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.23 Cr
as on 10-01-2025
- Revenue 156.57%
(FY 2022)
- Profit 279.38%
(FY 2022)
- Ebitda 43.77%
(FY 2022)
- Net Worth 39.60%
(FY 2022)
- Total Assets 12.72%
(FY 2022)
About Aislin Formulations
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹1.23 Cr.
Vishal Singla, Surinder Singla, and Mahesh Kumar serve as directors at the Company.
- CIN/LLPIN
U74900DL2009PTC191744
- Company No.
191744
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jun 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Aislin Formulations Private Limited offer?
Aislin Formulations Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Health Supplement, Herbal Juice, Cosmetics, Hair & Beauty Products, Hair Oil, Common Disease Medicines, Pharmaceutical Capsules, Juices, Soups & Soft Drinks, Fruit Juice, Digestive System Drugs & Medicines, Digestive Drugs.
Who are the key members and board of directors at Aislin Formulations?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Singla  | Director | 30-Jun-2009 | Current |
| Surinder Singla | Director | 30-Jun-2009 | Current |
| Mahesh Kumar | Additional Director | 25-Jun-2024 | Current |
Financial Performance of Aislin Formulations.
Aislin Formulations Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 156.57% increase. The company also saw a substantial improvement in profitability, with a 279.38% increase in profit. The company's net worth Soared by an impressive increase of 39.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aislin Formulations?
In 2022, Aislin Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹12.30 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 1.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jul 2021 | Axis Bank Limited | ₹1.23 Cr | Open |
How Many Employees Work at Aislin Formulations?
Unlock and access historical data on people associated with Aislin Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aislin Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aislin Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
